Eastern 0 7 0 7 B-clinical_variable
Cooperative 8 19 8 19 I-clinical_variable
Oncology 20 28 20 28 I-clinical_variable
Group 29 34 29 34 I-clinical_variable
( 35 36 35 36 I-clinical_variable
ECOG 36 40 36 40 I-clinical_variable
) 40 41 40 41 I-clinical_variable
performance 42 53 42 53 I-clinical_variable
status 54 60 54 60 I-clinical_variable
≤ 61 62 61 62 O
3 63 64 63 64 B-upper_bound

Evidence 0 8 65 73 O
of 9 11 74 76 O
hormone 12 19 77 84 O
sensitive 20 29 85 94 O
, 29 30 94 95 O
ER 31 33 96 98 O
rich 34 38 99 103 O
primary 39 46 104 111 B-cancer
tumor 47 52 112 117 I-cancer
defined 53 60 118 125 O
by 61 63 126 128 O
an 64 66 129 131 O
Allred 67 73 132 138 B-clinical_variable
score 74 79 139 144 I-clinical_variable
of 80 82 145 147 O
≥6 83 85 148 150 O

Female 0 6 151 157 B-gender

Histologically 0 14 158 172 O
confirmed 15 24 173 182 O
adenocarcinoma 25 39 183 197 B-cancer
of 40 42 198 200 I-cancer
the 43 46 201 204 I-cancer
breast 47 53 205 211 I-cancer

History 0 7 212 219 O
of 8 10 220 222 O
allergic 11 19 223 231 O
reactions 20 29 232 241 O
or 30 32 242 244 O
hypersensitivity 33 49 245 261 O
to 50 52 262 264 O
compounds 53 62 265 274 O
of 63 65 275 277 O
similar 66 73 278 285 O
chemical 74 82 286 294 O
or 83 85 295 297 O
biologic 86 94 298 306 O
composition 95 106 307 318 O
to 107 109 319 321 O
anastrozole 110 121 322 333 B-allergy_name
or 122 124 334 336 O
letrozole 125 134 337 346 B-allergy_name

Patients 0 8 347 355 O
must 9 13 356 360 O
have 14 18 361 365 O
an 19 21 366 368 O
adequate 22 30 369 377 O
tumor 31 36 378 383 B-cancer
tissue 37 43 384 390 O
sample 44 50 391 397 O
prior 51 56 398 403 O
to 57 59 404 406 O
enrollment 60 70 407 417 O
available 71 80 418 427 O
for 81 84 428 431 O
correlative 85 96 432 443 O
studies 97 104 444 451 O
as 105 107 452 454 O
defined 108 115 455 462 O
below 116 121 463 468 O
: 121 122 468 469 O
Core 123 127 470 474 B-treatment
needle 128 134 475 481 I-treatment
biopsy 135 141 482 488 I-treatment
or 142 144 489 491 O
incisional 145 155 492 502 B-treatment
biopsy 156 162 503 509 I-treatment
samples 163 170 510 517 O
that 171 175 518 522 O
can 176 179 523 526 O
provide 180 187 527 534 O
≥ 188 189 535 536 O
5 190 191 537 538 B-lower_bound
unstained 192 201 539 548 O
sections 202 210 549 557 O
of 211 213 558 560 O
5 214 215 561 562 O
micron 216 222 563 569 O
thickness 223 232 570 579 O

Patients 0 8 580 588 O
must 9 13 589 593 O
not 14 17 594 597 O
have 18 22 598 602 O
received 23 31 603 611 O
any 32 35 612 615 O
prior 36 41 616 621 B-treatment
chemotherapy 42 54 622 634 I-treatment
, 54 55 634 635 O
radiation 56 65 636 645 B-treatment
therapy 66 73 646 653 I-treatment
, 73 74 653 654 O
or 75 77 655 657 O
endocrine 78 87 658 667 B-treatment
therapy 88 95 668 675 I-treatment
for 96 99 676 679 O
their 100 105 680 685 O
current 106 113 686 693 O
breast 114 120 694 700 B-cancer
cancer 121 127 701 707 I-cancer

Patients 0 8 708 716 O
who 9 12 717 720 O
received 13 21 721 729 O
tamoxifen 22 31 730 739 B-treatment
or 32 34 740 742 O
raloxifene 35 45 743 753 B-treatment
or 46 48 754 756 O
another 49 56 757 764 O
agent 57 62 765 770 O
for 63 66 771 774 O
prevention 67 77 775 785 O
of 78 80 786 788 O
breast 81 87 789 795 B-cancer
cancer 88 94 796 802 I-cancer
may 95 98 803 806 O
be 99 101 807 809 O
included 102 110 810 818 O
as 111 113 819 821 O
long 114 118 822 826 O
as 119 121 827 829 O
the 122 125 830 833 O
patient 126 133 834 841 O
has 134 137 842 845 O
discontinued 138 150 846 858 O
the 151 154 859 862 O
treatment 155 164 863 872 B-treatment
at 165 167 873 875 O
least 168 173 876 881 O
one 174 177 882 885 B-lower_bound
month 178 183 886 891 I-lower_bound
prior 184 189 892 897 I-lower_bound
to 190 192 898 900 O
baseline 193 201 901 909 O
study 202 207 910 915 B-treatment
biopsy 208 214 916 922 I-treatment

Postmenopausal 0 14 923 937 O
status 15 21 938 944 O
, 21 22 944 945 O
defined 23 30 946 953 O
by 31 33 954 956 O
no 34 36 957 959 O
menstrual 37 46 960 969 O
cycle 47 52 970 975 O
for 53 56 976 979 O
12 57 59 980 982 O
months 60 66 983 989 O
or 67 69 990 992 O
surgical 70 78 993 1001 B-treatment
removal 79 86 1002 1009 I-treatment
of 87 89 1010 1012 I-treatment
ovaries 90 97 1013 1020 I-treatment

Previous 0 8 1021 1029 O
or 9 11 1030 1032 O
current 12 19 1033 1040 O
systemic 20 28 1041 1049 O
malignancy 29 39 1050 1060 B-cancer
within 40 46 1061 1067 O
the 47 50 1068 1071 O
past 51 55 1072 1076 B-upper_bound
3 56 57 1077 1078 I-upper_bound
years 58 63 1079 1084 I-upper_bound
other 64 69 1085 1090 O
than 70 74 1091 1095 O
breast 75 81 1096 1102 B-cancer
cancer 82 88 1103 1109 I-cancer
or 89 91 1110 1112 O
adequately 92 102 1113 1123 O
treated 103 110 1124 1131 O
cervical 111 119 1132 1140 B-cancer
carcinoma 120 129 1141 1150 I-cancer
in 130 132 1151 1153 I-cancer
situ 133 137 1154 1158 I-cancer
or 138 140 1159 1161 O
basal 141 146 1162 1167 B-cancer
/ 146 147 1167 1168 O
squamous 147 155 1168 1176 B-cancer
carcinoma 156 165 1177 1186 I-cancer
of 166 168 1187 1189 O
the 169 172 1190 1193 O
skin 173 177 1194 1198 O

Unresected 0 10 1199 1209 O
operable 11 19 1210 1218 O
breast 20 26 1219 1225 B-cancer
cancer 27 33 1226 1232 I-cancer
stage 34 39 1233 1238 B-lower_bound
I 40 41 1239 1240 I-lower_bound
- 41 42 1240 1241 O
III 42 45 1241 1244 B-upper_bound
with 46 50 1245 1249 O
primary 51 58 1250 1257 B-clinical_variable
tumor 59 64 1258 1263 I-clinical_variable
≥ 65 66 1264 1265 O
2.0 67 70 1266 1269 B-lower_bound
cm 71 73 1270 1272 I-lower_bound

greater 0 7 1273 1280 O
than 8 12 1281 1285 O
or 13 15 1286 1288 O
equal 16 21 1289 1294 O
to 22 24 1295 1297 O
18 25 27 1298 1300 B-lower_bound
years 28 33 1301 1306 I-lower_bound

